Claudio Catalani

Pharmacological profile of the novel mammalian tachykinin, hemokinin 1

Francesca Bellucci, Francesca Maria Carini, Claudio Catalani et al. · British Journal of Pharmacology · 2002 · 111 citations · Full text

Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation

Erika Terzuoli, Stefania Meini, Paola Cucchi et al. · PLoS ONE · 2014 · 48 citations · Full text

Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritis

Francesca Bellucci, Stefania Meini, Paola Cucchi et al. · Osteoarthritis and Cartilage · 2013 · 41 citations · Full text

Mechanobiology, Inflammation, Cartilage Degradation +13

MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization

Paola Cucchi, Stefania Meini, Alessandro Bressan et al. · European Journal of Pharmacology · 2005 · 36 citations

Molecular Pharmacology, Medicine, Receptor (Biochemistry) +8

Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists

Stefania Meini, Paola Cucchi, Francesca Bellucci et al. · Biochemical Pharmacology · 2003 · 30 citations

Signal Transduction, Biochemistry, Medicine +9